Cargando…

Stepwise in vitro screening of MMV pathogen box compounds against Plasmodium falciparum to identify potent antimalarial candidates

Development of resistance to deployed antimalarial drugs is inevitable and needs prompt and continuous discovery of novel candidate drugs. Therefore, the antimalarial activity of 125 compounds from the Medicine for Malaria Ventures (MMV) pathogen box was determined. Combining standard IC(50) and nor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mbye, Haddijatou, Bojang, Fatoumata, Jaiteh, Fatou Kene, Jawara, Aminata, Njie, Bekai, Correa, Simon, D'Alessandro, Umberto, Amambua-Ngwa, Alfred
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Regular article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394470/ https://www.ncbi.nlm.nih.gov/pubmed/37329848 http://dx.doi.org/10.1016/j.ijpddr.2023.05.005

Ejemplares similares

Tolerance of Gambian Plasmodium falciparum to Dihydroartemisinin and Lumefantrine Detected by Ex Vivo Parasite Survival Rate Assay
por: Mbye, Haddijatou, et al.
Publicado: (2020)

Plasmodium falciparum merozoite invasion ligands, linked antimalarial resistance loci and ex vivo responses to antimalarials in The Gambia
por: Mbye, Haddijatou, et al.
Publicado: (2022)

Recent increase in low complexity polygenomic infections and sialic acid-independent invasion pathways in Plasmodium falciparum from Western Gambia
por: Nganyewo, Nora Nghochuzie, et al.
Publicado: (2023)

Sustained Ex Vivo Susceptibility of Plasmodium falciparum to Artemisinin Derivatives but Increasing Tolerance to Artemisinin Combination Therapy Partner Quinolines in The Gambia
por: Amambua-Ngwa, Alfred, et al.
Publicado: (2017)

Long-distance transmission patterns modelled from SNP barcodes of Plasmodium falciparum infections in The Gambia
por: Amambua-Ngwa, Alfred, et al.
Publicado: (2019)

Multistage and transmission-blocking targeted antimalarials discovered from the open-source MMV Pandemic Response Box
por: Reader, Janette, et al.
Publicado: (2021)

Clinical isolates of uncomplicated falciparum malaria from high and low malaria transmission areas show distinct pfcrt and pfmdr1 polymorphisms in western Ethiopia
por: Tadele, Geletta, et al.
Publicado: (2023)

Low genetic diversity of Plasmodium falciparum merozoite surface protein 1 and 2 and multiplicity of infections in western Ethiopia following effective malaria interventions
por: Tadele, Geletta, et al.
Publicado: (2022)

Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183
por: de Vries, Laura E., et al.
Publicado: (2022)

Identification of β-hematin inhibitors in the MMV Malaria Box
por: Fong, Kim Y., et al.
Publicado: (2015)

The Candidate Antimalarial Drug MMV665909 Causes Oxygen-Dependent mRNA Mistranslation and Synergizes with Quinoline-Derived Antimalarials
por: Vallières, Cindy, et al.
Publicado: (2017)

Asymptomatic Plasmodium falciparum carriage and clinical disease: a 5-year community-based longitudinal study in The Gambia
por: Ahmad, Abdullahi, et al.
Publicado: (2023)

Structural characterization of the Plasmodium falciparum lactate transporter PfFNT alone and in complex with antimalarial compound MMV007839 reveals its inhibition mechanism
por: Peng, Xi, et al.
Publicado: (2021)

A sustainable, efficient, and potentially cost-effective approach to the antimalarial drug candidate MMV688533
por: Kavthe, Rahul D., et al.
Publicado: (2023)

Actives from MMV Open Access Boxes? A suggested way forward
por: Samby, Kirandeep, et al.
Publicado: (2021)

Identification of Plasmodium falciparum specific translation inhibitors from the MMV Malaria Box using a high throughput in vitro translation screen
por: Ahyong, Vida, et al.
Publicado: (2016)

Preliminary Structure–Activity Relationship Study of the MMV Pathogen Box Compound MMV675968 (2,4-Diaminoquinazoline) Unveils Novel Inhibitors of Trypanosoma brucei brucei
por: Dize, Darline, et al.
Publicado: (2022)

Discovery of New Chemical Tools against Leishmania amazonensis via the MMV Pathogen Box
por: López-Arencibia, Atteneri, et al.
Publicado: (2021)

A Screening of the MMV Pandemic Response Box Reveals Epetraborole as A New Potent Inhibitor against Mycobacterium abscessus
por: Kim, Taeho, et al.
Publicado: (2021)

MMV in partnership: the Eurartesim(®) experience
por: Ubben, David, et al.
Publicado: (2013)

Identification of MMV Malaria Box Inhibitors of Perkinsus marinus Using an ATP-Based Bioluminescence Assay
por: Alemán Resto, Yesmalie, et al.
Publicado: (2014)

New Derivatives of the Multi-Stage Active Malaria Box Compound MMV030666 and Their Antiplasmodial Potencies
por: Hermann, Theresa, et al.
Publicado: (2022)

Safety, Tolerability, Pharmacokinetics, and Antimalarial Activity of the Novel Plasmodium Phosphatidylinositol 4-Kinase Inhibitor MMV390048 in Healthy Volunteers
por: Sinxadi, Phumla, et al.
Publicado: (2020)

Antimalarial activity of Malaria Box Compounds against Plasmodium falciparum clinical isolates
por: Chirawurah, Jersley D., et al.
Publicado: (2017)

Screening of MMV pandemic response and pathogen box compounds against pan-drug-resistant Klebsiella pneumoniae to identify potent inhibitory compounds
por: Sivasankar, Seshan, et al.
Publicado: (2023)

Assessment of antimalarial drug resistant markers in asymptomatic Plasmodium falciparum infections after 4 years of indoor residual spraying in Northern Ghana
por: Myers-Hansen, James L., et al.
Publicado: (2020)

Development of Potent PfCLK3 Inhibitors Based on TCMDC-135051 as a New Class of Antimalarials
por: Mahindra, Amit, et al.
Publicado: (2020)

A screening of the MMV Pathogen Box® reveals new potential antifungal drugs against the etiologic agents of chromoblastomycosis
por: Coelho, Rowena Alves, et al.
Publicado: (2020)

Diaminoquinazoline MMV675968 from Pathogen Box inhibits Acinetobacter baumannii growth through targeting of dihydrofolate reductase
por: Songsungthong, Warangkhana, et al.
Publicado: (2019)

MMV560185 from pathogen box induces extrinsic pathway of apoptosis in Theileria annulata infected bovine leucocytes
por: Araveti, Prasanna Babu, et al.
Publicado: (2022)

Clinical manifestations and outcomes of severe malaria in adult patients admitted to a tertiary hospital in the Gambia
por: Bittaye, Sheikh Omar, et al.
Publicado: (2022)

Robenidine Analogues Are Potent Antimalarials in Drug-Resistant Plasmodium falciparum
por: Krollenbrock, Alina, et al.
Publicado: (2021)

In Vitro Activities of MMV Malaria Box Compounds against the Apicomplexan Parasite Neospora caninum, the Causative Agent of Neosporosis in Animals
por: Müller, Joachim, et al.
Publicado: (2020)

New possibilities for chromoblastomycosis and phaeohyphomycosis treatment: identification of two compounds from the MMV Pathogen Box(®) that present synergism with itraconazole
por: Coelho, Rowena Alves, et al.
Publicado: (2022)

Exceptionally long-range haplotypes in Plasmodium falciparum chromosome 6 maintained in an endemic African population
por: Amambua-Ngwa, Alfred, et al.
Publicado: (2016)

High prevalence and extended deletions in Plasmodium falciparum hrp2/3 genomic loci in Ethiopia
por: Golassa, Lemu, et al.
Publicado: (2020)

Discovery of Anti-Amoebic Inhibitors from Screening the MMV Pandemic Response Box on Balamuthia mandrillaris, Naegleria fowleri, and Acanthamoeba castellanii
por: Rice, Christopher A., et al.
Publicado: (2020)

Lipid peroxidation: pathophysiological and pharmacological implications in the eye
por: Njie-Mbye, Ya Fatou, et al.
Publicado: (2013)

Repurposing the Medicines for Malaria Venture’s COVID Box to discover potent inhibitors of Toxoplasma gondii, and in vivo efficacy evaluation of almitrine bismesylate (MMV1804175) in chronically infected mice
por: dos Santos, Bruna Ramos, et al.
Publicado: (2023)

Pyrazoleamide compounds are potent antimalarials that target Na(+) homeostasis in intraerythrocytic Plasmodium falciparum
por: Vaidya, Akhil B., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_74gno4mu6csosm1624epemh6iu